The largest database of trusted experimental protocols

Plcdh cir vector

Manufactured by RiboBio
Sourced in China

The PLCDH-cir vector is a laboratory tool used for molecular biology research. It serves as a circular plasmid DNA construct that can be utilized in various experimental procedures. The core function of this vector is to provide a platform for DNA manipulation and expression studies, though its specific applications may vary depending on the research context.

Automatically generated - may contain errors

10 protocols using plcdh cir vector

1

Overexpression and Knockdown of circBMPR2 in Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
All the cells were purchased from the American Type Culture Collection (Manassas, VA, USA). MCF-7, MDA-MB-231, MDA-MB-468, and HEK293T cells were cultured in DMEM. T47D, SKBR3, and ZR-75-1 cells were cultured in RPMI 1640 medium. The medium was supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 μg/mL streptomycin. Cells in the medium were incubated in a humidified atmosphere containing 5% CO2 at 37°C.
We constructed circBMPR2-overexpressed vector as previously reported.48 (link) Briefly, the sequences of exons 2 and 3 of BMPR2 with a full length of 342 bp was subcloned into a pLCDH-ciR vector (RiboBio, Guangzhou, China) to generate pLCDH-circBMPR2 constructs. The subcloned sequence containing a front circular frame (SA), back circular frame (SD) of circRNA biogenesis and full length of circBMPR2, and 5′-TGAAATATGCTATCTTACAG-circBMPR2-GTGAATATATTTTTTCTTGA-3′ was directly synthesized. The pLCDH-ciR empty vector was used as an NC. For the knockdown experiments, the small interfering RNA (siRNA) target sequences for circBMPR2 were as follows: sense: 5′-CACCACUCACUUCGCAGAATT-3′; antisense: 5′-UUCUGCGAAGUGAGUGGUGTT-3′. The sequences for NC siRNA were as follows: sense: 5′-UUCUCCGAACGUGUCACGUTT-3′; antisense: 5′-ACGUGACACGUUCGGAGAATT-3′. The procedure of transfection was performed using Lipofectamine 2000 (Invitrogen) as previously reported.48 (link)
+ Open protocol
+ Expand
2

Regulating circ_0018414 and DKK1 in LUAD

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sequence of circ_0018414 was inserted into the PLCDH-cir vector (Ribobio, Guangzhou, China) to produce lentivirus for circ_0018414 overexpression. Short hairpin RNA (shRNA) targeting circ_0018414 (sh-circ_0018414) was applied for downregulating circ_0018414. In order to upregulate DKK1, the full-length of the DKK1 cDNA sequence was cloned into the pcDNA3.1 vector (GenePharma, Shanghai, China). miR-6807-3p mimics/inhibitor were gained from GenePharma, with negative control (NC) mimics/inhibitor as corresponding NCs. All of the plasmids were transfected into LUAD cells by the use of Lipofectamine 3000 (Invitrogen).
+ Open protocol
+ Expand
3

Overexpression of circ-ITCH in BCa cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The BCa cell lines were purchased from the Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China) and cultured with DMEM medium (Gibco, USA) containing 10% fetal bovine serum (FBS). The cells were cultured at 37 °C in a humidified incubator containing 5% CO2. To overexpress circ-ITCH, a fragment of 873 bp of cDNA was cloned into PLCDH-cir vector (Ribobio, Guangzhou, China) and lentivirus was constructed by Hanbio (Shanghai, China). The procedure of transfection was conducted as previously described according to the manufacturer’s instructions [24 (link)].
+ Open protocol
+ Expand
4

Regulation of Gastric Cancer Cell Lines by CircRNA hsa_circ_0072309

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human GC cell lines including AGS and MKN-45 cells, as well as the normal gastric epithelial cell line, GES-1, were obtained from the American Type Culture Collection. The cell lines were cultured in RPMI-1640 (Invitrogen; Thermo Fisher Scientific, Inc.) or DMEM (Gibco; Thermo Fisher Scientific, Inc.) supplemented with 100 U/ml penicillin/streptomycin and 10% FBS (Gibco; Thermo Fisher Scientific, Inc.) and incubated at 37°C in a humidified incubator containing 5% CO2. AGS cells were pretreated with PPARγ agonist (pioglitazone, 20 µM) or PPARγ antagonist (GW9662, 2 µM) for 6 h at 37°C.
The coding sequence of hsa_circ_0072309 was cloned into the PLCDH-cir vector (Guangzhou RiboBio Co., Ltd.) for hsa_circ_0072309 overexpression. The 100 nM overexpression vector (Oe)-circ_0072309 or an empty vector, used as negative controls, (Vector Laboratories, Inc.; Maravai Life Sciences) were transfected into the AGS cells (2×106/well) using Lipofectamine® 3000 reagent (Invitrogen; Thermo Fisher Scientific, Inc.), following the manufacturer's instructions. After 48 h transfection, the AGS cells were used for further experiments and reverse transcription-quantitative (RT-q) PCR was performed to confirm the transfection efficiency.
+ Open protocol
+ Expand
5

Generation of circRNA-overexpression and knockdown models

Check if the same lab product or an alternative is used in the 5 most similar protocols
To generate hsa_circRNA_102209 or RIN1 overexpression model, wildtype (WT; o/e‐102209 or o/e‐RIN1) as well as mutant (o/e‐NC) fragment was inserted into PLCDH‐cir vector (Ribobio). In hsa_circRNA_102209 knockdown model, shRNA sequences against hsa_circRNA_102209 (sh‐102209) or negative control (sh‐NC) were obtained from Genepharm Co. Ltd. (Shanghai, China). After annealing, shRNA were integrated into lentiviral pU6‐Luc‐Puro vector (Genepharm Co. Ltd.). The lentiviral vectors were obtained from Hanbio (Shanghai, China). Transfection was carried out according to the manufacturer's protocols. CRC cells were selected by 0.5ug/mL puromycin (Sigma‐Aldrich) 2 weeks post‐transfection. To establish the knockdown model of hsa_circRNA_102209, pooled siRNA targeting hsa_circRNA_102209 (si‐102209) and negative control (si‐NC) were purchased from Genepharm Co. Ltd. The mimics/inhibitors of miR‐761 and corresponding negative control (NC) were synthesized by Genepharm Co. Ltd (Shanghai, China). The mimics/inhibitors (100pM) and siRNA (50 nM) were transfected into CRC cells using Lipofectamine®2000 (Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer's protocols. The culture medium was replenished with fresh DMEM supplemented with 10% FBS 8 hours post‐transfection. The transfection efficiency was evaluated using RT‐qPCR.
+ Open protocol
+ Expand
6

Establishing Circ_SFMBT2 Overexpression and Knockdown Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
To establish the circ_SFMBT2 overexpression model, wild-type (WT; o/e-circ_SFMBT2) or mutant (o/e-NC) circ_SFMBT2 fragment was integrated into PLCDH-cir vector (Ribobio). The lentiviral vector was generated by Hanbio. Transfection was performed according to the manufacturer’s protocols. Glioma cells were selected using 0.5 µg/mL puromycin (Sigma-Aldrich) for 2 weeks. To generate the circ_SFMBT2 knockdown model, small interfering RNA (siRNA) sequences targeting circ_SFMBT2 (si-SFMBT2; GTCGGTGACTAAGCAATCAAA) and negative control (NC) were designed and synthesized by Genepharm Co Ltd. The mimic or inhibitor of miR-182-5p and the corresponding NC were purchased from Genepharm Co Ltd. The mimics, inhibitors (100 pM), and siRNA (50 nM) were transfected into glioma cells using Lipofectamine 2000 (Invitrogen; Thermo Fisher Scientific, Inc) according to the manufacturer’s protocols. At 8 hours posttransfection, the culture medium was replenished with fresh DMEM containing 10% FBS. The transfection efficiency was confirmed by reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
+ Open protocol
+ Expand
7

Overexpression of circ_0008726 in cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For circ_0008726 overexpression, the circ_0008726 sequence was cloned into the PLCDH-cir vector (RiboBio, Guangzhou, China) [9 , 10 (link)]. The empty PLCDH-cir vector was the negative control (NC). Control siRNA, siRNA for circ_0008726, miR-345-3p mimic, miR-345-3p inhibitor, and the NC (miR-NC) were synthesized from Life Technologies (Carlsbad, CA). Transfections of above molecules into the cells were performed by Lipofectamine 3000 (Invitrogen, Carlsbad, CA) following the manufacturer’s protocol. Four microgram plasmid and 200 nM of miR-345-3p mimic, inhibitor, or the NC (miR-NC) were used for transfecting cells in 6-well plate with 80% confluency. Forty-eight hours after transfection, cells were harvested for further experiments.
+ Open protocol
+ Expand
8

Overexpression of circCACTIN and TGFBR1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Small interference RNAs (siRNAs) specific to human circCACTIN and TGFBR1, miR-331-3p mimic, inhibitor and their negative controls were generated by Gene-Pharma (Shanghai, China). A fragment of 420bp of circCACTIN cDNA was cloned into PLCDH-cir vector (Ribobio, Guangzhou, China) to overexpress circCACTIN. For TGFBR1 overexpression, the 1509bp coding sequence of TGFBR1 (NM_004612) was cloned into pLVX-IRES-Puro (Promega, USA). The lentivirus in this study were constructed by Genelily (Shanghai, China). The above vectors were transfected by Lipofectamine® 3000 (Thermo fisher, China) according to the manufacturer's instructions. After transfection for 48h, the transfection efficiency of cells in each group was detected by qRT-PCR.
+ Open protocol
+ Expand
9

Overexpression of hsa_circ_0072309 in Breast Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human breast cancer cell lines MCF-7 and T47D were obtained from the cell bank of the Chinese Academy of Science, Shanghai and maintained at 37°C in 5% CO2/95% air in DMEM (Hyclone, Thermo Fisher Scientific, Waltham, MA, USA) containing 10% FBS, 100 units/mL penicillin, and 100 µg/mL streptomycin.
MCF-7 and T47D cells stably overexpressing hsa_ circ_0072309 were constructed as previously reported.13 (link) In brief, the coding sequence of hsa_circ_0072309 was inserted into the PLCDH-cir vector (Ribobio, Guangzhou, China). The lentiviral vector was constructed by Hanbio (Shanghai, China). Transfection was performed in accordance with the manufacturer’s instructions. MCF-7 and T47D cells were selected with 0.5 µg/mL puromycin (Sigma-Aldrich Co., St Louis, MO, USA) for 2 weeks. MiR-492 mimics (5’-AGGAC-CUGCGGGACAAGAUUCUU-3’) or negative controls were synthesized by Genepharma (Shanghai, China) and transfected into cell lines using Lipofectamine 2000 (Invitrogen, Thermo Fisher Scientific) following the manufacturer’s instructions. Transfection efficiency was confirmed through qRT-PCR.
+ Open protocol
+ Expand
10

Overexpressing hsa_circ_0023409 in Gastric Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to overexpress hsa_circ_0023409 in MKN45 cells, a fragment of cDNA was cloned into PLCDH-cir vector (Ribobio, Guangzhou, China) and lentivirus was constructed by Hanbio (Shanghai, China). We purchased the lentivirus-containing short hairpin RNA (shRNA) targeting hsa_circ_0023409 from GenePharma (Shanghai, China). The shRNAs were transfected into the HGC-27 cell lines using Lipofectamine 3000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions. Forty-eight hours after transfection, qRT-PCR was performed to verify the transfection efficiency.
For transient transfection, miR-542-3p mimics and the negative control (NC) mimic, as well as the miR-542-3p inhibitor were purchased from RiboBio. The miR-542-3p mimics or its NC was transfected into HGC-27 cells. MKN45 cells were transfected with miR-542-3p inhibitor or its NC inhibitor. The transfections were mediated by Lipofectamine 3000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions for 6 h at 37°C.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!